ArticlePsychopharmacology2026
Galantamine as add-on therapy to escitalopram: enhancing antidepressant therapeutic potential via. Targeting α7nAChR/BDNF/KYN signalling.
Shivanshu Bajaj et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it